Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells
- 1 February 2009
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 77 (3), 348-363
- https://doi.org/10.1016/j.bcp.2008.10.018
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: A SAR studyInvestigational New Drugs, 2008
- Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship studyInvestigational New Drugs, 2008
- MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh TranslocationImmunity, 2008
- Bcl-2–family proteins and hematologic malignancies: history and future prospectsBlood, 2008
- p53 Enhances Gefitinib-Induced Growth Inhibition and Apoptosis by Regulation of Fas in Non–Small Cell Lung CancerCancer Research, 2007
- Hydantoin Derivatives of L- and D-amino acids: Synthesis and Evaluation of Their Antiviral and Antitumoral ActivityMolecules, 2006
- Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocationsDNA Repair, 2006
- Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small moleculesJournal of Fluorine Chemistry, 2006
- Fluorine in medicinal chemistry: A review of anti-cancer agentsJournal of Fluorine Chemistry, 2006
- p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancerJournal of Surgical Oncology, 2003